Studies
Drug-Induced Liver Injury Network (DILIN)
Drug-Induced Liver Injury Network (DILIN)
Request Access
Overview
Selected Publications (10)
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
M. I. Lucena, M. Molokhia, Yufeng Shen, et al.. (2011). Gastroenterology. Cited 468 times.
https://doi.org/10.1053/j.gastro.2011.04.001
Drug-Induced Liver Injury Network (DILIN) Prospective Study
R. Fontana, P. Watkins, H. Bonkovsky, et al.. (2009). Drug Safety. Cited 315 times.
https://doi.org/10.2165/00002018-200932010-00005
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
E. Bjornsson, R. Andrade, A. Sawle, et al.. (2017). Gastroenterology. Cited 205 times.
https://doi.org/10.1053/j.gastro.2016.12.016
Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
T. Urban, P. Nicoletti, N. Chalasani, et al.. (2017). Journal of hepatology. Cited 122 times.
https://doi.org/10.1016/j.jhep.2017.03.010
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs
T. Urban, Yufeng Shen, A. Stolz, et al.. (2012). Pharmacogenetics and Genomics. Cited 120 times.
https://doi.org/10.1097/FPC.0b013e3283589a76
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
Elizabeth T. Cirulli, P. Nicoletti, Karen Abramson, et al.. (2019). Gastroenterology. Cited 119 times.
https://doi.org/10.1053/j.gastro.2019.01.034
HLA‐B*35:01 and Green Tea–Induced Liver Injury
J. Hoofnagle, H. Bonkovsky, E. Phillips, et al.. (2020). Hepatology. Cited 73 times.
https://doi.org/10.1002/hep.31538
Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim‐Sulfamethoxazole Induced Liver Injury
Yi-Ju Li, E. Phillips, A. Dellinger, et al.. (2020). Hepatology. Cited 46 times.
https://doi.org/10.1002/hep.31258
The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
R. Fontana, Elizabeth Theresa Cirulli, Jiezhun Gu, et al.. (2018). Journal of hepatology. Cited 39 times.
https://doi.org/10.1016/j.jhep.2018.08.004
Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver Injury
H. Bonkovsky, Tyler J Severson, P. Nicoletti, et al.. (2019). Hepatology Communications. Cited 9 times.
https://doi.org/10.1002/hep4.1382
